NCT00225615View on ClinicalTrials.gov

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

June 30, 2006

Conditions
Phenylketonurias
Interventions
DRUG

sapropterin dihydrochloride

Trial Locations (14)

Unknown

Los Angeles

Oakland

Sacramento

San Jose

New Haven

Atlanta

Chicago

Minneapolis

St Louis

New York

Portland

Dallas

Salt Lake City

Madison

Sponsors
All Listed Sponsors
lead

BioMarin Pharmaceutical

INDUSTRY